← Back to Search

Procedure

Group 1: Matrix Pro for Acne Scars

N/A
Waitlist Available
Led By Konika Schallen, MD
Research Sponsored by Candela Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy Male or Female Age 18 to 75
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline and at 3 month follow up
Awards & highlights

Study Summary

This trial is testing a device called Profound Matrix for treating wrinkles and acne scars. Participants will receive either up to three treatments with the Matrix Pro applicator or up to five treatments with the Sublime

Who is the study for?
This trial is for individuals with acne scars, skin enlargement issues, or wrinkles. Participants will undergo treatments using the Profound Matrix™ System. The exact eligibility criteria are not provided, but typically participants should be in good health and meet specific requirements set by the study.Check my eligibility
What is being tested?
The Profound Matrix™ System is being tested for its effectiveness on treating acne scars and wrinkles. Participants may receive up to three treatments with the Matrix Pro applicator or five with Sublime/Sublative RF applicators in a non-randomized, open-label setting across multiple centers.See study design
What are the potential side effects?
While specific side effects are not listed here, similar procedures may include risks like temporary redness, swelling at treatment sites, discomfort during application, potential burns from RF energy and rare chances of scarring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 75 years old and in good health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline and at 3 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at baseline and at 3 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acne scar appearance improvement (Group 1 and Group 3 only)
Wrinkle reduction (Group 1 and Group 3 only)
Secondary outcome measures
Group 2 wrinkle acne scar appearance improvement
Group 2 wrinkle reduction

Trial Design

3Treatment groups
Experimental Treatment
Group I: Modified Matrix ProExperimental Treatment1 Intervention
Subjects undergoing treatment with a Matrix Pro Modified applicator with lower RF power settings.
Group II: Group 2: Sublime/SublativeExperimental Treatment1 Intervention
Subjects undergoing treatment with either 1) Sublime applicator only, 2) Sublative RF applicator only, 3) Combined treatment of Sublime and Sublative RF applicators.
Group III: Group 1: Matrix ProExperimental Treatment1 Intervention
Subjects undergoing treatment with the Matrix Pro applicator.

Find a Location

Who is running the clinical trial?

Candela CorporationLead Sponsor
19 Previous Clinical Trials
1,772 Total Patients Enrolled
1 Trials studying Acne Scars
15 Patients Enrolled for Acne Scars
Konika Schallen, MDPrincipal InvestigatorCandela Medical
1 Previous Clinical Trials
60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In how many locations is this trial currently being conducted?

"Among the available trial sites, Syneron Medical in Yoqne'am 'Illit and NY Derm in New york are two examples. Additionally, the Candela Institute for Excellence located in Marlborough is another location participating in this study."

Answered by AI

Is the recruitment phase of this clinical trial still ongoing?

"According to the information available on clinicaltrials.gov, this specific clinical trial is no longer actively seeking participants. The trial was initially posted on October 28th, 2020 and its most recent update occurred on December 21st, 2023. However, it's worth noting that there are currently 106 other studies actively searching for eligible candidates at this time."

Answered by AI

Are individuals who are older than 20 years eligible to participate in this particular medical study?

"To be eligible for participation, individuals between the ages of 18 and 75 are required. There are a total of 15 clinical trials available exclusively for patients under 18 years old, while there are 83 trials specifically designed for participants over the age of 65."

Answered by AI

Which individuals meet the criteria to be eligible for participation in this research investigation?

"To be eligible for enrollment in this research study, potential participants must possess acne scars and fall between the ages of 18 and 75. The trial aims to recruit approximately 193 individuals."

Answered by AI

Who else is applying?

What site did they apply to?
OptiSkin
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Functional Usability and Feasibility Testing of the Profound Matrix™ System
2020. "Functional Usability and Feasibility Testing of the Profound Matrix™ System". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06192550.
All > Hypertrophy
~43 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top